What is the best first choice treatment option for Helicobacter pylori?

References (12)

1. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection-- the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther. 2002; 6: 167-80
2. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection – The Maastricht III Consensus Report. Gut 2007 Jan 17; [Epub] 3. Bochenek WJ, Peters S, Fraga PD, et al. Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies. Helicobacter. 2003; 8: 626-42
3. Palmas F, Pellicano R, Massimetti E et al. Eradication of Helicobacter pylori infection with proton pump inhibitorbased triple therapy. A randomised study. Panminerva Med 2002; 44: 145-7
4. Sivri B, Simsek I, Hulagu S, et al. The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H. pylori eradication and duodenal ulcer healing. Curr Med Res Opin 2004; 20: 1301-7
5. Sezgin O, Altintas E, Ucbilek E, et al. Bismuth-based therapies for the first step eradication of Helicobacter pylori. Turk J Gastroenterol 2006; 17: 90-3
6. Kadayifci A, Simsek H, Tatar G. The efficiency of omeprazole and dual antibiotic treatment schemes for H. pylori eradication. Turk J Gastroenterol 1996; 7: 228-32
7. Uygun A, Ates Y, Erdil A, et al. Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population. Clin Ther 1999; 21: 1539-48
8. Uygun A, Kadayifci A, Yesilova Z, et al. Recent success of pantoprazole or lansoprazole based clarithromycin plus amoxicillin treatment in the eradication of H. pylori. Turk J Gastroenterol 2004; 15: 219-24
9. Kadayifci A, Buyukhatipoglu H, Savas MC, et al. Eradication of Helicobacter pylori with triple therapy: An Epidemiologic Anaysis of Trends in Turkey over 10 years. Clin Ther 2006; 11: 1960-6
10. Uygun A, Yesilova Z, Ates Y, et al. Hp pozitif non-ülser dispepsili hastalarda 1. basamakta ranitidin bizmut sitrat’lı 3 farklı tedavi rejiminin karsılastırılması. Turk J Gastroenterol 2005 (Suppl); SB.01/11
11. Perez Aldana L, Kato M, Nakagawa S, et al. The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance. Helicobacter 2002; 7: 306–9
12. Toracchio S, Marzio L. Primary and secondary antibiotic resistance of Helicobacter